Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Probiotics

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...

Microbiota Modulation by Antibiotics

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

Dysbiosis of the Gut Microbiota

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Functions of the Gut Microbiota

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Zeitschrift fur Gastroenterologie·2022

Same author

Zeitschrift fur Gastroenterologie·2021

Same author

European Society of Coloproctology: guidelines for the management of diverticular disease of the colon.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020

Same author

Synchronous pathologic findings in patients with colorectal cancer and preoperative incomplete colonoscopy.

International journal of colorectal disease·2019

Same author

Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn's Disease: Results from a Prospective German Registry.

Journal of Crohn's & colitis·2018

Same author

Editorial: mesalazine to prevent recurrent acute diverticulitis-the final nail in the coffin. Authors' reply.

Alimentary pharmacology & therapeutics·2017

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Probiotics: do they help to control intestinal inflammation?

S K Böhm¹, W Kruis

¹Evangelisches Krankenhaus Kalk, Abteilung für Innere Medzin, Universität Zu Köln, Buchforststrasse 2, Köln, Germany. boehm@evkk.de

Annals of the New York Academy of Sciences

|October 24, 2006

Summary

The gut microbiome significantly impacts inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Probiotic therapies, utilizing beneficial bacteria, are increasingly recognized for managing these conditions and pouchitis.

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4⁺ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Related Experiment Videos

Last Updated: Jul 19, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4⁺ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Area of Science:

Gastroenterology
Immunology
Microbiology

Background:

Growing evidence links gut bacteria to inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.
High bacterial concentrations in the gut are associated with IBD, and manipulating bacterial load affects symptoms.
Genetic factors like NOD2/CARD15 mutations impair bacterial clearance, highlighting the microbiome's role.

Purpose of the Study:

To explore the role of the enteric flora in gastrointestinal health and disease.
To review the established and emerging applications of probiotic therapy in IBD.
To highlight the dynamic research at the intersection of gastroenterology, immunology, and microbiology regarding probiotics.

Main Methods:

Review of existing scientific literature on the gut microbiome and IBD.
Analysis of clinical observations and experimental models related to bacterial flora and colitis.
Examination of the therapeutic efficacy of probiotics in ulcerative colitis and pouchitis.

Main Results:

Commensal gut bacteria play a crucial role in the pathogenesis of Crohn's disease and ulcerative colitis.
Reduction of enteric bacterial concentration can mitigate IBD symptoms.
Probiotics are effective in maintenance therapy for ulcerative colitis and pouchitis, with potential for primary prevention.

Conclusions:

The enteric flora is integral to gastrointestinal health and disease.
Probiotic therapy is a valuable approach for managing IBD and related conditions.
Further research into probiotic mechanisms will drive the development of more effective formulations.